1. Home
  2. EYPT vs BWMN Comparison

EYPT vs BWMN Comparison

Compare EYPT & BWMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • BWMN
  • Stock Information
  • Founded
  • EYPT 1987
  • BWMN 1995
  • Country
  • EYPT United States
  • BWMN United States
  • Employees
  • EYPT N/A
  • BWMN N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • BWMN Military/Government/Technical
  • Sector
  • EYPT Industrials
  • BWMN Consumer Discretionary
  • Exchange
  • EYPT Nasdaq
  • BWMN Nasdaq
  • Market Cap
  • EYPT 484.4M
  • BWMN 454.6M
  • IPO Year
  • EYPT 2005
  • BWMN 2021
  • Fundamental
  • Price
  • EYPT $8.25
  • BWMN $26.65
  • Analyst Decision
  • EYPT Strong Buy
  • BWMN Strong Buy
  • Analyst Count
  • EYPT 8
  • BWMN 3
  • Target Price
  • EYPT $24.29
  • BWMN $34.17
  • AVG Volume (30 Days)
  • EYPT 895.1K
  • BWMN 72.2K
  • Earning Date
  • EYPT 05-07-2025
  • BWMN 08-05-2025
  • Dividend Yield
  • EYPT N/A
  • BWMN N/A
  • EPS Growth
  • EYPT N/A
  • BWMN N/A
  • EPS
  • EYPT N/A
  • BWMN 0.15
  • Revenue
  • EYPT $56,042,000.00
  • BWMN $444,588,000.00
  • Revenue This Year
  • EYPT N/A
  • BWMN $16.66
  • Revenue Next Year
  • EYPT N/A
  • BWMN $6.70
  • P/E Ratio
  • EYPT N/A
  • BWMN $176.47
  • Revenue Growth
  • EYPT 12.04
  • BWMN 21.78
  • 52 Week Low
  • EYPT $3.91
  • BWMN $17.90
  • 52 Week High
  • EYPT $13.99
  • BWMN $36.65
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 72.87
  • BWMN 65.99
  • Support Level
  • EYPT $5.46
  • BWMN $24.78
  • Resistance Level
  • EYPT $8.36
  • BWMN $25.60
  • Average True Range (ATR)
  • EYPT 0.57
  • BWMN 0.80
  • MACD
  • EYPT 0.24
  • BWMN -0.02
  • Stochastic Oscillator
  • EYPT 96.21
  • BWMN 85.53

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About BWMN Bowman Consulting Group Ltd.

Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.

Share on Social Networks: